PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells

Molecular and Cellular Biology

Volumn 29, Issue 17, 2009, Pages 4612-4622

  Wei, Fang ^a   Zaprazna, Kristina ^a   Wang, Junwen ^b   Atchison, Michael L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; PROTEIN BCL 6; TRANSCRIPTION FACTOR PU 1;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSFECTION; GERMINAL CENTER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SOMATIC HYPERMUTATION; TRANSCRIPTION REGULATION; TRANSIENT EXPRESSION;

ANIMALS; B-LYMPHOCYTES; DNA; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULINS; INTRONS; MICE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANS-ACTIVATORS;

EID: 68849111429     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00234-09     Document Type: Article

References (57)

1. Ahmad, K. F., A. Melnick, S. Lax, D. Bouchard, J. Liu, C.-L. Kiang, S. Mayer, S. Takahashi, J. D. Licht, and G. G. Prove. 2003. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell 12:1551-1564.
2. Allen, C. D. C., T. Okada, and J. G. Cyster. 2007. Germinal-center organization and cellular dynamics. Immunity 27:190-202.
3. Allman, D., A. Jain, A. L. Dent, R. R. Maile, T. Selvaggi, R. Kehry, and L. M. Staudt. 1996. BCL-6 expression during B-cell activation. Blood 87:5257-5268.
4. Atchison, M. L., O. Meyuhas, and R. P. Perry. 1989. Localization of transcriptional regulatory elements and nuclear factor binding sites in mouse ribosomal protein gene rpL32. Mol. Cell. Biol. 9:2067-2074.
5. Bai, Y., L. Srinivasan, L. Perkins, and M. L. Atchison. 2005. Protein acetylation regulates both PU.1 transactivation and Igκ 3′ enhancer activity. J. Immunol. 175:5160-5169.
6. Baron, B. W., J. Anastasi, M. J. Thirman, Y. Furukawa, S. Fears, D. C. Kim, F. Simone, M. Birkenbach, A. Montag, A. Sadhu, N. Zeleznik-Le, and T. W. McKeithan. 2002. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the downregulation of apoptosis. Proc. Natl. Acad. Sci. USA 99:2860-2865.
7. Baron, B. W., G. Nucifora, N. McCabe, R. I. Espinosa, M. M. Le Beau, and T. W. McKeithan. 1993. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc. Natl. Acad. Sci. USA 90:5262-5266.
8. Betz, A. G., C. Milstein, A. Gonzalel-Fernandez, R. Pannell, T. Larson, and M. S. Neuberger. 1994. Elements regulating somatic hypermutation of an Igκ gene: critical role of the intron enhancer/matrix attachment region. Cell 77:239-248.
9. Chang, C. C., B. H. Ye, R. S. Chaganti, and R. Dalla-Favera. 1996. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA 93:6947-6952.
10. Dent, A. L., A. L. Shaffer, X. Yu, D. Allman, and L. M. Staudt. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589-592.
11. Dent, A. L., F. H. Vasanwala, and L. M. Toney. 2002. Regulation of gene expression by the proto-oncogene BCL-6. Crit. Rev. Oncol. Hematol. 41:1-9.
12. Dhordain, P., O. Albagli, R. J. Lin, S. Ansieeau, S. Quief, A. Leutz, J.-P. Kerckaert, R. M. Evans, and D. Leprince. 1997. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA 94:10762-10767.
13. Fujita, N., D. L. Jaye, C. Geigerman, A. Akyildiz, M. R. Mooney, J. M. Boss, and P. A. Wade. 2004. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119:75-86.
14. Fukuda, B. T., T. Yoshida, S. Okada, M. Hatano, T. Miki, K. Ishibashi, S. Okabe, H. Koseki, S. Hirosawa, M. Taniguchi, N. Miyasaka, and T. Tokuhisa. 1997. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186:439-448.
15. Goyenechea, B., N. Klix, J. Yelamos, G. T. Williams, A. Riddell, M. S. Neuberger, and C. Milstein. 1997. Cells strongly expressing Igκ transgenes show clonal recruitment and hypermutation: a role for both MAR and the enhancers. EMBO J. 16:3987-3994.
16. Henderson, A., and K. Calame. 1998. Transcriptional regulation during B cell development. Annu. Rev. Immunol. 16:163-200.
17. Hiramatsu, R., K. Akagi, M. Matsuoka, K. Sakumi, H. Nakamura, L. Kingsbury, C. David, R. R. Hardy, K.-I. Yamamura, and H. Sakano. 1995. The 3′ enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin Vκ-Jκ joining. Cell 83:1113-1123.
18. Huynh, K. D., W. Fischle, E. Verdin, and V. J. Bardwell. 2000. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 14:1810-1823.
19. Kimura, T., Y. Kadokawa, H. Harada, M. Matsumoto, M. Sato, Y. Kashiwazaki, M. Tarutani, R. Sok-Pin Tan, T. Takasugi, T. Matsuyama, T. W. Mak, S. Noguchi, and T. Taniguchi. 1996. Essential and non-redundant roles of p48 (ISGF3gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1:115-124.
20. Klein, U., Y. Tu, G. A. Stolovitzky, J. L. Keller, J. J. Haddad, V. Miljkovic, G. Cattoretti, A. Califano, and R. Dalla-Favera. 2003. Transcriptional analysis of the B cell germinal center reaction. Proc. Natl. Acad. Sci. USA 100:2639-2644.
21. Lemercier, C., M.-P. Brocard, F. Puvion-Dutilleul, H.-Y. Kao, O. Albagli, and S. Khochbin. 2002. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J. Biol. Chem. 277:22045- 22052.
22. Lin, K.-I., C. Tunyaplin, and K. Calame. 2003. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194:19-28.
23. Matys, V., O. V. Kel-Margoulis, E. Fricke, I. Liebich, S. Land, A. Barre-Dirrie, I. Reuter, D. Chekmenev, M. Krull, K. Hornischer, N. Voss, P. Stegmaier, B. Lewicki-Potapov, H. Saxel, A. E. Kel, and E. Wingender. 2006. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 34:D108-D110.
24. Nagulapalli, S., and M. L. Atchison. 1998. Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol. Cell. Biol. 18:4639-4650.
25. Nagulapalli, S., A. Goheer, L. Pitt, L. P. McIntosh, and M. L. Atchison. 2002. Mechanism of E47-Pip interaction on DNA resulting in transcriptional synergy and activation of immunoglobulin germ line sterile transcripts. Mol. Cell. Biol. 22:7337-7350.
26. Nagulapalli, S., J. M. R. Pongubala, and M. L. Atchison. 1995. Multiple proteins physically interact with PU.1. J. Immunol. 155:4330-4338.
27. Niu, H., G. Cattoretti, and R. Dalla-Favera. 2003. BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells. J. Exp. Med. 198:211-221.
28. Park, K., and M. L. Atchison. 1991. Isolation of a candidate repressor/activator, NF-E1 (YY-1, δ), that binds to the immunoglobulin κ 3′ enhancer and the immunoglobulin heavy-chain μE1 site. Proc. Natl. Acad. Sci. USA 88:9804-9808.
29. Perkel, J. M., and M. L. Atchison. 1998. A two-step mechanism for recruitment of Pip by PU.1. J. Immunol. 160:241-252.
30. Phan, R. T., and R. Dalla-Favera. 2004. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432:635-639.
31. Phan, R. T., M. Saito, K. Basso, H. Niu, and R. Dalla-Favera. 2005. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol. 6:1054-1060.
32. Pongubala, J. M. R., and M. L. Atchison. 1991. Functional characterization of the developmentally controlled immunoglobulin kappa 3′ enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol. Cell. Biol. 11:1040-1047.
33. Pongubala, J. M. R., and M. L. Atchison. 1997. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proc. Natl. Acad. Sci. USA 94:127-132.
34. Pongubala, J. M. R., S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1992. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol. Cell. Biol. 12:368-378.
35. Pongubala, J. M. R., C. Van Beveren, S. Nagulapalli, M. J. Klemsz, S. R. McKercher, R. A. Maki, and M. L. Atchison. 1993. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1622-1625.
36. Ranuncolo, S. M., J. M. Polo, J. Dierov, M. Singer, T. Kuo, G. Greally, R. Green, M. Carrol, and A. Melnick. 2007. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat. Immunol. 8:705-714.
37. Reljic, R., S. D. Wagner, L. J. Peakman, and D. T. Fearon. 2000. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J. Exp. Med. 192:1841-1847.
38. Rossbacher, J., A. M. Haberman, S. Neschen, A. Khalil, and M. J. Schlomchik. 2006. Antibody-independent B cell-intrinsic and -extrinsic roles for CD21/35. Eur. J. Immunol. 36:2384-2393.
39. Seyfert, V. L., D. Allman, Y. He, and L. M. Staudt. 1996. Transcriptional repression by the proto-oncogene BCL6. Oncogene 12:2331-2342.
40. Shaffer, A. L., X. Yu, Y. He, J. Boldrick, E. P. Chan, and L. M. Staudt. 2000. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212.
41. Sharpe, M. J., C. Milstein, J. M. Jarvis, and M. S. Neuberger. 1991. Somatic hypermutation of immunoglobulin κ may depend on sequences 3′ of Cκ and occurs on passenger transgenes. EMBO J. 10:2139-2145.
42. Shinall, S. M., M. Gonzalez-Fernandez, R. J. Noelle, and T. J. Waldschmidt. 2000. Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens. J. Immunol. 164: 5729-5738.
43. Takeda, N., M. Arima, N. Tsuruoka, S. Okada, M. Hatano, A. Sakamoto, Y. Kohno, and T. Tokuhisa. 2003. Bcl6 is a transcriptional repressor for the IL-18 gene. J. Immunol. 171:426-431.
44. Thibault, D. L., A. D. Chu, K. L. Graham, I. Balboni, L. Y. Lee, C. Kohlmoos, A. Landrigan, J. P. Higgins, T. Tibshirani, and P. J. Utz. 2008. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J. Clin. Investig. 118:1417-1426.
45. Toney, L. M., G. Cattoretti, T. Graf, T. Merghoub, P.-P. Pandolfi, R. Dalla-Favera, B. H. Ye, and A. L. Dent. 2000. BCL-6 regulates chemokine gene transcription in macrophages. Nat. Immunol. 1:214-220.
46. Torlakovic, E., A. Malecka, J. H. Myklebust, A. Tierens, H.-C. Aasheim, J. M. Nesland, E. Smeland, S. Kvaloy, and J. Delabie. 2005. PU.1 protein expression has positive linear association with protein expression in germinal center B cell genes including BCL-6, CD10, CD20, and CD22: identification of PU.1 putative binding sites in the BCL-6 promoter. J. Pathol. 206:312-319.
47. van der Stoep, N., J. R. Gorman, and F. W. Alt. 1998. Reevaluation of 3′Eκ function in stage- and lineage-specific rearrangement and somatic hypermutation. Immunity 8:743-750.
48. Vasanwala, F. H., S. Kusam, L. M. Toney, and A. L. Dent. 2002. Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J. Immunol. 169:1922-1929.
49. Wang, J., and S. Hannenhalli. 2006. A mammalian promoter model links cis elements to genetic networks. Biochem. Biophys. Res. Commun. 347:166-177.
50. Wang, J., S. Zhang, R. M. Schultz, and H. Tseng. 2006. Search for basonuclin target genes. Biochem. Biophys. Res. Commun. 348:1261-1271.
51. - cells after primary NP challenge in mice. J. Immunol. 177:2072-2079.
52. Wong, C. W., and M. L. Privalsky. 1998. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARa, and BCL-6. J. Biol. Chem. 273:27695-27702.
53. Yamashita, R., Y. Suzuki, H. Wakaguri, K. Tsuritani, K. Nakai, and S. Sugano. 2006. DBTSS: DataBase of Human Transcription Start Sites, progress report 2006. Nucleic Acids Res. 34:D86-D89.
54. Ye, B. H., G. Cattroretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. Nouri-Shirazi, A. Orazi, R. S. K. Chaganti, P. Rothman, A. M. Stall, P.-P. Pandolfi, and R. Dalla-Favera. 1997. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16:161-170.
55. Ye, B. H., P. H. Rao, R. S. K. Chaganti, and R. Dalla-Favera. 1993. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in B-cell lymphoma. Cancer Res. 53:2732-2735.
56. Yoon, H., G. Laxmikanthan, J. Lee, S. I. Blaber, A. Rodriguez, J. M. Kogot, I. A. Scarisbrick, and M. Blaber. 2007. Activation profiles and regulatory cascades of the human kallikrein-related peptidases. J. Biol. Chem. 282:31852-31864.
57. Zhang, H., S. Okada, M. Hatano, S. Okabe, and T. Tokuhisa. 2001. A new functional domain of Bcl6 family that recruits histone deacetylases. Biochim. Biophys. Acta 1540:188-200.